Page last updated: 2024-09-03

ici d2138 and thromboxane b2

ici d2138 has been researched along with thromboxane b2 in 2 studies

Compound Research Comparison

Studies
(ici d2138)
Trials
(ici d2138)
Recent Studies (post-2010)
(ici d2138)
Studies
(thromboxane b2)
Trials
(thromboxane b2)
Recent Studies (post-2010) (thromboxane b2)
23207,483715485

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crawley, GC; Foster, SJ; McMillan, RM; Spruce, KE; Walker, ER1
Buckner, CK; Dea, DM; DeHaas, CJ; Krell, RD; Kusner, EJ; Marks, RL1

Other Studies

2 other study(ies) available for ici d2138 and thromboxane b2

ArticleYear
Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
    British journal of pharmacology, 1992, Volume: 107, Issue:4

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Guinea Pigs; Hydroxyurea; Inflammation; Knee Joint; Leukotriene B4; Lipoxygenase Inhibitors; Macrophages; Male; Mice; Oxidation-Reduction; Pyrans; Quinolones; Rabbits; Rats; Thromboxane B2

1992
The 5-lipoxygenase inhibitors ZD2138 and ZM230487 are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses.
    European journal of pharmacology, 1994, May-23, Volume: 257, Issue:3

    Topics: Airway Resistance; Animals; Antigens; Cyclooxygenase Inhibitors; Guinea Pigs; Histamine Release; Indoles; Leukotrienes; Lipoxygenase Inhibitors; Lung; Male; Phospholipases A; Phospholipases A2; Pyrans; Quinolones; Thromboxane B2; Thromboxane-A Synthase

1994